Synergy between systemic toxicity and genotoxicity: relevance to human cancer risk.
The health risk manager and policy analyst must frequently make recommendations based upon incomplete toxicity data. This is a situation which is encountered in the evaluation of human carcinogenic risks as animal cancer bioassay results are often not available. In this study, in order to assess the relevance of other possible indicators of carcinogenic risks, we used the "chemical diversity approach" to estimate the magnitude of the human carcinogenic risk based upon Salmonella mutagenicity and systemic toxicity data of the "universe of chemicals" to which humans have the potential to be exposed. Analyses of the properties of 10,000 agents representative of the "universe of chemicals" suggest that chemicals that have genotoxic potentials as well as exhibiting greater systemic toxicity are more likely to be carcinogens than non-genotoxicants or agents that exhibit lesser toxicity. Since "genotoxic" carcinogenicity is a hallmark of recognized human carcinogens, these findings are relevant to human cancer risk assessment.
Rosenkranz
Herbert S
HS
Department of Biomedical Sciences, Florida Atlantic University, 777 Glades Road, PO Box 3091, Boca Raton, FL 33431, USA. rosenkra@fau.edu
D002273:Carcinogens / Q000633:toxicity*; D004269:DNA, Bacterial / Q000187:drug effects / Q000235:genetics; D004357:Drug Synergism; D006801:Humans; D009152:Mutagenicity Tests; D009153:Mutagens / Q000633:toxicity*; D009369:Neoplasms / Q000139:chemically induced / Q000453:epidemiology*; D018570:Risk Assessment; D012486:Salmonella typhimurium / Q000187:drug effects* / Q000235:genetics; D014116:Toxicology / Q000379:methods
D002273:Carcinogens; D004269:DNA, Bacterial; D009153:Mutagens